SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 9/30/19 – ‘ZIP’

On:  Friday, 11/8/19, at 7:14pm ET   ·   As of:  11/12/19   ·   For:  9/30/19   ·   Accession #:  1564590-19-42402   ·   File #:  1-36385

Previous ‘10-Q’:  ‘10-Q’ on 8/9/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/8/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/19  Biolase, Inc                      10-Q        9/30/19   86:10M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    792K 
 7: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     95K 
 2: EX-10.5     Material Contract                                   HTML     55K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
54: R1          Document and Entity Information                     HTML     78K 
32: R2          Consolidated Balance Sheets (Unaudited)             HTML    111K 
39: R3          Consolidated Balance Sheets (Unaudited)             HTML     47K 
                (Parenthetical)                                                  
83: R4          Consolidated Statements Of Operations And           HTML     97K 
                Comprehensive Loss (Unaudited)                                   
52: R5          Consolidated Statements of Stockholders' (Deficit)  HTML     58K 
                Equity (Unaudited)                                               
31: R6          Consolidated Statements Of Cash Flows (Unaudited)   HTML    134K 
38: R7          Description of Business and Basis of Presentation   HTML     42K 
81: R8          Summary of Significant Accounting Policies          HTML     40K 
55: R9          Revenue Recognition                                 HTML    215K 
48: R10         Stockholders' (Deficit) Equity                      HTML    300K 
21: R11         Inventory                                           HTML     46K 
64: R12         Property, Plant, and Equipment                      HTML     67K 
73: R13         Intangible Assets and Goodwill                      HTML     29K 
47: R14         Accrued Liabilities                                 HTML    117K 
20: R15         Debt                                                HTML    103K 
63: R16         Leases                                              HTML     74K 
72: R17         Commitments and Contingencies                       HTML     34K 
46: R18         Segment Information                                 HTML     75K 
22: R19         Concentrations                                      HTML    114K 
50: R20         Income Taxes                                        HTML     31K 
79: R21         Subsequent Events                                   HTML     36K 
34: R22         Summary of Significant Accounting Policies          HTML     77K 
                (Policies)                                                       
24: R23         Revenue Recognition (Tables)                        HTML    296K 
49: R24         Stockholders' (Deficit) Equity (Tables)             HTML    304K 
78: R25         Inventory (Tables)                                  HTML     47K 
33: R26         Property, Plant, and Equipment (Tables)             HTML     66K 
23: R27         Accrued Liabilities (Tables)                        HTML    118K 
51: R28         Debt (Tables)                                       HTML     79K 
77: R29         Leases (Tables)                                     HTML     75K 
74: R30         Segment Information (Tables)                        HTML     76K 
66: R31         Concentrations (Tables)                             HTML    166K 
18: R32         Description of Business and Basis of Presentation   HTML     69K 
                - Additional Information (Detail)                                
44: R33         Summary of Significant Accounting Policies -        HTML     36K 
                Additional Information (Detail)                                  
75: R34         Revenue Recognition - Additional Information        HTML     38K 
                (Detail)                                                         
67: R35         Summary of Opening and Closing Balances of          HTML     36K 
                Contract Liabilities (Detail)                                    
19: R36         Summary of Disaggregation of Revenues Related to    HTML     32K 
                Geographic Areas (Detail)                                        
45: R37         Summary of Revenues Disaggregated by Timing of      HTML     33K 
                Goods and Services Transferred (Detail)                          
76: R38         Summary of Sales by End Market (Detail)             HTML     33K 
65: R39         Summary of Percentages of Sales by Product line     HTML     40K 
                (Detail)                                                         
80: R40         Stockholders' (Deficit) Equity - Additional         HTML     84K 
                Information (Detail)                                             
56: R41         Classification of Compensation Expense Associated   HTML     38K 
                with Share-Based Payments (Detail)                               
29: R42         Assumptions Used in Estimating Fair Value of Stock  HTML     34K 
                Options Granted (Detail)                                         
40: R43         Summary of Option Activity (Detail)                 HTML     65K 
82: R44         Summary of Unvested Stock Option Activity (Detail)  HTML     47K 
57: R45         Cash Proceeds Along with Fair Value Disclosures     HTML     33K 
                Related to Grants, Exercises and Vested Options                  
                (Detail)                                                         
30: R46         Summary of Unvested Restricted Stock Units          HTML     50K 
                (Detail)                                                         
41: R47         Summary of Warrant Activity (Detail)                HTML     43K 
84: R48         Components of Inventory (Detail)                    HTML     35K 
53: R49         Inventory - Additional Information (Detail)         HTML     28K 
61: R50         Summary of Property, Plant, and Equipment (Detail)  HTML     49K 
70: R51         Property, Plant, and Equipment - Additional         HTML     28K 
                Information (Detail)                                             
43: R52         Intangible Assets and Goodwill - Additional         HTML     34K 
                Information (Detail)                                             
17: R53         Components of Accrued Liabilities (Detail)          HTML     52K 
60: R54         Changes in Initial Product Warranty Accrual and     HTML     41K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
69: R55         Accrued Liabilities - Additional Information        HTML     33K 
                (Detail)                                                         
42: R56         Debt - Summary of Principal Outstanding and         HTML     33K 
                Unamortized Discount (Detail)                                    
16: R57         Debt - Additional Information (Detail)              HTML    209K 
62: R58         Debt - Summary of Future Minimum Principal and      HTML     49K 
                Interest Payments (Detail)                                       
68: R59         Leases - Additional Information (Detail)            HTML     59K 
37: R60         Leases - Information related to Right-of-use        HTML     34K 
                Assets and Liabilities (Detail)                                  
27: R61         Leases - Schedule of Maturities of Lease            HTML     39K 
                Liabilities (Detail)                                             
59: R62         Leases - Future Minimum Rental Commitments Under    HTML     35K 
                Lease Agreements (Detail)                                        
86: R63         Commitments and Contingencies - Additional          HTML     56K 
                Information (Detail)                                             
36: R64         Segment Information - Additional Information        HTML     39K 
                (Detail)                                                         
26: R65         Summary of Net Revenue by Geographic Location       HTML     32K 
                (Detail)                                                         
58: R66         Summary of Property, Plant and Equipment by         HTML     33K 
                Geographic Location (Detail)                                     
85: R67         Concentrations - Summary of Net Revenue from        HTML     51K 
                Various Products (Detail)                                        
35: R68         Concentrations - Additional Information (Detail)    HTML     41K 
28: R69         Income Taxes - Additional Information (Detail)      HTML     37K 
15: R70         Subsequent Events - Additional Information          HTML     88K 
                (Detail)                                                         
14: XML         IDEA XML File -- Filing Summary                      XML    153K 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX     91K 
 8: EX-101.INS  XBRL Instance -- biol-20190930                       XML   2.79M 
10: EX-101.CAL  XBRL Calculations -- biol-20190930_cal               XML    170K 
11: EX-101.DEF  XBRL Definitions -- biol-20190930_def                XML    583K 
12: EX-101.LAB  XBRL Labels -- biol-20190930_lab                     XML   1.39M 
13: EX-101.PRE  XBRL Presentations -- biol-20190930_pre              XML   1.06M 
 9: EX-101.SCH  XBRL Schema -- biol-20190930                         XSD    215K 
25: ZIP         XBRL Zipped Folder -- 0001564590-19-042402-xbrl      Zip    178K 


‘ZIP’   —   XBRL Zipped Folder — 0001564590-19-042402-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:biol-20190930.xml
biol-20190930.xsd
biol-20190930_cal.xml
biol-20190930_def.xml
biol-20190930_lab.xml
biol-20190930_pre.xml


11 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/03/23  Biolase, Inc.                     S-1/A                  6:1M                                     Donnelley … Solutions/FA
12/12/22  Biolase, Inc.                     S-1/A                  7:1.1M                                   Donnelley … Solutions/FA
11/22/22  Biolase, Inc.                     S-1                    3:655K                                   Donnelley … Solutions/FA
 3/17/22  Biolase, Inc.                     10-K       12/31/21   88:18M                                    Donnelley … Solutions/FA
11/10/21  Biolase, Inc.                     10-Q        9/30/21   84:13M                                    Donnelley … Solutions/FA
 8/13/21  Biolase, Inc.                     10-Q        6/30/21   80:12M                                    Donnelley … Solutions/FA
 5/13/21  Biolase, Inc.                     10-Q        3/31/21   81:9.4M                                   Donnelley … Solutions/FA
 3/31/21  Biolase, Inc.                     10-K       12/31/20   88:15M                                    ActiveDisclosure/FA
12/08/20  Biolase, Inc.                     S-1/A                  3:585K                                   Donnelley … Solutions/FA
11/13/20  Biolase, Inc.                     10-Q        9/30/20   81:11M                                    ActiveDisclosure/FA
 8/14/20  Biolase, Inc.                     10-Q        6/30/20   89:12M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-19-042402   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 10:18:22.2am ET